An important step to translate single-cell measurement into clinical practice: Stereoscopic cells

Abstract

Clinical single-cell biomedicine is an emerging disciplines within molecular medicine that brings more advanced alternatives for disease diagnoses and therapies. With the rapid development of biotechnologies such as Stereo-seq and Stereo-cell, it is now possible to explore the spatiotemporal and dynamical changes of intracellular element and organelle locations, distributions, and functional and morphological phenomes in stereological single cells at multiple layers and orientations. Stereological single cells (StereoCell) will provide the precise multidimensional information on molecular interactions, organelle communications, and signaling pathways, as well as on the interventions involving small molecule-, protein-, and cell-based therapies with targets. This is achieved by integrating morphological images, molecular multi-omics, and clinical phenomics. StereoCell is one of biotechnological breakthroughs and milestones during of clinical translation of single-cell measurements to pathology, biochemistry, hematology, and bioliquid tests. It is also a new approach to discover and develop new diagnostic biomarkers and therapeutic targets, and a new way to dynamically monitor the disease progression and therapeutic effects. Thus, we believe that SereoCell, detected by Stereo-seq and Stereo-cell, will provide new insights into human diseases and reforming clinical practices.

Keywords

biomedicine / clinical / stereology / single-cell / stereo-cell / stereo-seq

References

[1] Liu X, Wang DC, Powell CA, Wang X. Challenges of clinical translation from single-cell sequencing to measures in clinical biochemistry of haematology: definition of immune cell identities. Clin Transl Med. 2023; 13(9):e1401.

[2] Liu F, Liu X, Powell CA, et al. Initiative of clinical single-cell biomedicine in clinical and translational medicine. Clin Transl Med. 2023; 13(1):e1173.

[3] Wang X, Fan J. Spatiotemporal molecular imaging is a critical part of spatiotemporal molecular medicine. Clin Transl Med. 2021; 11(3):e347.

[4] Wang X, Fan J. Spatiotemporal molecular medicine: a new era of clinical and translational medicine. Clin Transl Med. 2021; 11(1):e294.

[5] Chen A, Liao S, Cheng M, et al. Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays. Cell. 2022; 185(10): 1777-1792.e21.

[6] Wei X, Fu S, Li H, et al. Single-cell Stereo-Seq reveals induced progenitor cells involved in axolotl brain regeneration. Science. 2022; 377(6610):eabp9444.

[7] Wang W, Liu X, Wang DC. Single-cell and spatial alterations of neural cells and circuits in clinical and translational medicine. Clin Transl Med. 2024; 14(6):e1696.

[8] Liao S, Zhou X, Liu C, et al. Stereo-cell: spatial enhanced resolution single-cell sequencing with high-density DNA nanoball-patterned arrays. Science. 2025; 389(6762):eadr0475.

[9] Wang X, Powell CA, Ma Q, Fan J. Clinical and translational mode of single-cell measurements: an artificial intelligent single-cell. Clin Transl Med. 2024; 14(9):e1818.

[10] Baumgartner C, Brislinger D. Transforming precision medicine: the potential of the clinical artificial intelligent single-cell framework. Clin Transl Med. 2025; 15(1):e70096.

[11] Liu L, Chen A, Li Y, Mulder J, Heyn H, Xu X. Spatiotemporal omics for biology and medicine. Cell. 2024; 187(17): 4488-4519.

[12] Ianevski A, Giri AK, Aittokallio A. Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data. Nat Commun. 2022; 13(1): 1246.

[13] Liu X, Xu G, Chen C, Song Y, Wang W, Wang X. Evaluation of pulmonary single-cell identity specificity in scRNA-seq analysis. Clin Transl Med. 2022; 12(12):e1132.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.